NEWBRYNewbury Pharmaceuticals ABNEWBRY info
$0.29info0.00%24h
Global rank34246
Market cap$5.66M
Change 7d-10.84%
YTD Performance-5.73%
SP500 benchmarkUnderperform
P/E-0.29
P/S5.63
Revenue$1.01M
Earnings-$1.90M
Dividend yield-
Main Sector
Healthcare
Category
Pharma
Biotech
Medical Care
Genomics
Stock data
Business data

Newbury Pharmaceuticals AB Revenue data

According to Newbury Pharmaceuticals AB latest financial reports the company had revenue of $1.01M in 2023-08-31, a 86.11% increase from 2022. Newbury Pharmaceuticals AB highest revenue was $1.01M in 2023.

Revenue history for Newbury Pharmaceuticals AB from 2021 to 2024

-
Value:-

Newbury Pharmaceuticals AB revenue by year

YearRevenueChange
2023$1.01M86.11%
2022$540.33K94.98%
2021$277.12K-

View the top revenue stocks arrow right

logo
Info
Popular Categories
Popular Countries
Facebook Icon
Twitter Icon
Linkedin Icon
© 2024 Topstocks.org